290 related articles for article (PubMed ID: 20067562)
1. The impact of donor type and ABO incompatibility on transfusion requirements after nonmyeloablative haematopoietic cell transplantation.
Wang Z; Sorror ML; Leisenring W; Schoch G; Maloney DG; Sandmaier BM; Storb R
Br J Haematol; 2010 Apr; 149(1):101-10. PubMed ID: 20067562
[TBL] [Abstract][Full Text] [Related]
2. ABO mismatch may affect engraftment in multiple myeloma patients receiving nonmyeloablative conditioning.
Badros A; Tricot G; Toor A; Morris C; Guo C; Munshi N; Barlogie B; Cottler-Fox M
Transfusion; 2002 Feb; 42(2):205-9. PubMed ID: 11896336
[TBL] [Abstract][Full Text] [Related]
3. ABO incompatibility does not affect transfusion requirements or clinical outcomes of unrelated cord blood transplantation after myeloablative conditioning for haematological malignancies.
Chen Y; Wan X; Cao Y; Wang H; Han D; Zhang Y; Yao W; Song K; Fan Q; Zhu X; Sun Z; Liu H
Blood Transfus; 2022 Mar; 20(2):156-167. PubMed ID: 34369864
[TBL] [Abstract][Full Text] [Related]
4. Severe immune hemolysis after minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation occurs more frequently after nonmyeloablative than myeloablative conditioning.
Worel N; Greinix HT; Keil F; Mitterbauer M; Lechner K; Fischer G; Mayr W; Höcker P; Kalhs P
Transfusion; 2002 Oct; 42(10):1293-301. PubMed ID: 12423513
[TBL] [Abstract][Full Text] [Related]
5. Decreased transfusion requirements for patients receiving nonmyeloablative compared with conventional peripheral blood stem cell transplants from HLA-identical siblings.
Weissinger F; Sandmaier BM; Maloney DG; Bensinger WI; Gooley T; Storb R
Blood; 2001 Dec; 98(13):3584-8. PubMed ID: 11739160
[TBL] [Abstract][Full Text] [Related]
6. Engraftment of early erythroid progenitors is not delayed after non-myeloablative major ABO-incompatible haematopoietic stem cell transplantation.
Maciej Zaucha J; Mielcarek M; Takatu A; Little MT; Gooley T; Baker J; Maloney DG; Sandmaier BM; Maris M; Chauncey T; Storb R; Torok-Storb B
Br J Haematol; 2002 Dec; 119(3):740-50. PubMed ID: 12437653
[TBL] [Abstract][Full Text] [Related]
7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
8. Graft-versus-host disease and donor-directed hemagglutinin titers after ABO-mismatched related and unrelated marrow allografts: evidence for a graft-versus-plasma cell effect.
Mielcarek M; Leisenring W; Torok-Storb B; Storb R
Blood; 2000 Aug; 96(3):1150-6. PubMed ID: 10910936
[TBL] [Abstract][Full Text] [Related]
9. After major ABO-mismatched allogeneic hematopoietic progenitor cell transplantation, erythroid engraftment occurs later in patients with donor blood group A than donor blood group B.
Schetelig J; Breitschaft A; Kröger N; Zabelina T; Ebell W; Bornhäuser M; Haack A; Ehninger G; Salama A; Siegert W;
Transfusion; 2005 May; 45(5):779-87. PubMed ID: 15847669
[TBL] [Abstract][Full Text] [Related]
10. Prolonged isolated red blood cell transfusion requirement after allogeneic blood stem cell transplantation: identification of patients at risk.
Dahl D; Hahn A; Koenecke C; Heuft HG; Dammann E; Stadler M; Buchholz S; Krauter J; Eder M; Sykora KW; Klein C; Ganser A; Sauer M
Transfusion; 2010 Mar; 50(3):649-55. PubMed ID: 19929861
[TBL] [Abstract][Full Text] [Related]
11. Red blood cell and platelet transfusion support in the first 30 and 100 days after allogeneic hematopoietic cell transplant.
Yuan S; Yang D; Nakamura R; Zhuang L; Al Malki MM; Karanes C; Wang S
Transfusion; 2020 Oct; 60(10):2225-2242. PubMed ID: 32743866
[TBL] [Abstract][Full Text] [Related]
12. RBC and platelet transfusion support in the first 30 and 100 days after haploidentical hematopoietic stem cell transplantation.
Yuan S; Yang D; Nakamura R; Zhuang L; Al Malki MM; Wang S
Transfusion; 2019 Nov; 59(11):3371-3385. PubMed ID: 31599972
[TBL] [Abstract][Full Text] [Related]
13. Donor-to-Recipient ABO Mismatch Does Not Impact Outcomes of Allogeneic Hematopoietic Cell Transplantation Regardless of Graft Source.
Damodar S; Shanley R; MacMillan M; Ustun C; Weisdorf D
Biol Blood Marrow Transplant; 2017 May; 23(5):795-804. PubMed ID: 28232088
[TBL] [Abstract][Full Text] [Related]
14. Consequences of ABO incompatibility in multiple myeloma patients undergoing peripheral blood stem cell transplantation after reduced intensity conditioning.
Marenchino D; Maddalena L; Balbo R; Avonto I; Menardi G; Prucca M; Perotti L; Mordini N; Peano G
Blood Transfus; 2011 Jan; 9(1):79-85. PubMed ID: 21084015
[TBL] [Abstract][Full Text] [Related]
15. Higher Anti-A/B isoagglutinin titers of IgG class, but not of IgM, are associated with increased red blood cell transfusion requirements in bone marrow transplantation with major ABO-mismatch.
De Santis GC; Garcia-Silva AC; Dotoli GM; de Castro PT; Simões BP; Covas DT
Clin Transplant; 2017 Apr; 31(4):. PubMed ID: 28160319
[TBL] [Abstract][Full Text] [Related]
16. Impact of donor-recipient major ABO mismatch on allogeneic transplantation outcome according to stem cell source.
Blin N; Traineau R; Houssin S; Peffault de Latour R; Petropoulou A; Robin M; Larghero J; Ribaud P; Socié G
Biol Blood Marrow Transplant; 2010 Sep; 16(9):1315-23. PubMed ID: 20353831
[TBL] [Abstract][Full Text] [Related]
17. Impact of peri-transplant RBC transfusion and ABO incompatibility on acute graft-versus-host disease in pediatric hematopoietic stem cell transplant patients.
Sever T; Kirkiz S; Kaya Z; Kocak U
Transfus Apher Sci; 2022 Jun; 61(3):103352. PubMed ID: 35074273
[TBL] [Abstract][Full Text] [Related]
18. ABO blood group incompatibility as an adverse risk factor for outcomes in patients with myelodysplastic syndromes and acute myeloid leukemia undergoing HLA-matched peripheral blood hematopoietic cell transplantation after reduced-intensity conditioning.
Hefazi M; Litzow M; Hogan W; Gastineau D; Jacob E; Damlaj M; Hashmi S; Al-Kali A; Patnaik MM
Transfusion; 2016 Feb; 56(2):518-27. PubMed ID: 26446051
[TBL] [Abstract][Full Text] [Related]
19. Transfusion requirements after bone marrow transplantation from HLA-identical siblings: effects of donor-recipient ABO incompatibility.
Mehta J; Powles R; Singhal S; Horton C; Hamblin M; Zomas A; Saso R; Treleaven J
Bone Marrow Transplant; 1996 Jul; 18(1):151-6. PubMed ID: 8832008
[TBL] [Abstract][Full Text] [Related]
20. [ABO-incompatible nonmyeloablative allogeneic peripheral blood stem cell transplantation].
Sun WJ; Guo M; Qiao JH; Yu CL; Wang DH; Sun QY; Zhang S; Li X; Ai HS
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):39-42. PubMed ID: 15748433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
